Trademarkia Logo

Australia

AU$
NEURALPLEXER
Accepted: Awaiting publication

Last updated on 6 Mar 2025

Owner Info

Iambic Therapeutics, Inc.

5627 Oberlin Drive, Suite 120

San Diego, California, 92121 UNITED STATES OF AMERICA,

Serial Number

2528124 filed on 6 Mar 2025

Correspondent

Gilbert + Tobin Lawyers

GPO Box 3810,

Sydney, NSW, 2001 AUSTRALIA,

NEURALPLEXER

Classification Information


Class [042]
Drug discovery services; platform as a service (PAAS) featuring a computer software platform for using artificial intelligence for collecting, analyzi Read More

Mark Details


Serial Number

2528124

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

21 Jan 2025

Mark Type

US

Legal History


Show more

Status DateAction Taken
6th Mar 2025Early Acceptance Notice correspondence sent
6th Mar 2025Status change to Accepted
6th Mar 2025Awaiting examination
6th Mar 2025Examination expedited
6th Mar 2025IP Right Filed correspondence sent
6th Mar 2025IP Right Filed Published
6th Mar 2025Status change to Published
6th Mar 2025Minimum Filing Requirements Considered
6th Mar 2025Status change to Filed
6th Mar 2025Status change to Received